147 related articles for article (PubMed ID: 23220169)
1. Biliary findings assist in predicting enlargement of intraductal papillary mucinous neoplasms of the pancreas.
Matsuzaki J; Suzuki H; Okuda S; Tanimoto A; Asakura K; Fukuhara S; Okada S; Hirata K; Mori H; Masaoka T; Higuchi H; Hozawa S; Kuribayashi S; Takebayashi T; Hibi T
Clin Gastroenterol Hepatol; 2013 May; 11(5):548-54. PubMed ID: 23220169
[TBL] [Abstract][Full Text] [Related]
2. Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study.
Rautou PE; Lévy P; Vullierme MP; O'Toole D; Couvelard A; Cazals-Hatem D; Palazzo L; Aubert A; Sauvanet A; Hammel P; Hentic O; Rebours V; Pelletier AL; Maire F; Ruszniewski P
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):807-14. PubMed ID: 18304885
[TBL] [Abstract][Full Text] [Related]
3. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms.
Tanno S; Nakano Y; Koizumi K; Sugiyama Y; Nakamura K; Sasajima J; Nishikawa T; Mizukami Y; Yanagawa N; Fujii T; Okumura T; Obara T; Kohgo Y
Pancreas; 2010 Jan; 39(1):36-40. PubMed ID: 19745777
[TBL] [Abstract][Full Text] [Related]
5. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
[TBL] [Abstract][Full Text] [Related]
7. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
8. Management strategy for multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas.
Mori Y; Ohtsuka T; Kono H; Ideno N; Aso T; Nagayoshi Y; Takahata S; Nakamura M; Ishigami K; Aishima S; Oda Y; Tanaka M
Pancreas; 2012 Oct; 41(7):1008-12. PubMed ID: 22850621
[TBL] [Abstract][Full Text] [Related]
9. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
[TBL] [Abstract][Full Text] [Related]
10. Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.
Kim KW; Park SH; Pyo J; Yoon SH; Byun JH; Lee MG; Krajewski KM; Ramaiya NH
Ann Surg; 2014 Jan; 259(1):72-81. PubMed ID: 23657084
[TBL] [Abstract][Full Text] [Related]
11. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
[TBL] [Abstract][Full Text] [Related]
12. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
[TBL] [Abstract][Full Text] [Related]
13. Does a family history of pancreatic ductal adenocarcinoma and cyst size influence the follow-up strategy for intraductal papillary mucinous neoplasms of the pancreas?
Mandai K; Uno K; Yasuda K
Pancreas; 2014 Aug; 43(6):917-21. PubMed ID: 24743378
[TBL] [Abstract][Full Text] [Related]
14. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas.
Yoon LS; Catalano OA; Fritz S; Ferrone CR; Hahn PF; Sahani DV
J Comput Assist Tomogr; 2009; 33(3):363-8. PubMed ID: 19478628
[TBL] [Abstract][Full Text] [Related]
15. Development of Pancreatic Cancer, Disease-specific Mortality, and All-Cause Mortality in Patients with Nonresected IPMNs: A Long-term Cohort Study.
Nagata N; Kawazoe A; Mishima S; Wada T; Shimbo T; Sekine K; Watanabe K; Imbe K; Kojima Y; Kumazawa K; Mihara F; Tokuhara M; Edamoto Y; Igari T; Yanase M; Mizokami M; Akiyama J; Uemura N
Radiology; 2016 Jan; 278(1):125-34. PubMed ID: 26172534
[TBL] [Abstract][Full Text] [Related]
16. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas.
Ingkakul T; Sadakari Y; Ienaga J; Satoh N; Takahata S; Tanaka M
Ann Surg; 2010 Jan; 251(1):70-5. PubMed ID: 20009749
[TBL] [Abstract][Full Text] [Related]
17. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results.
Tanno S; Nakano Y; Nishikawa T; Nakamura K; Sasajima J; Minoguchi M; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y
Gut; 2008 Mar; 57(3):339-43. PubMed ID: 17660227
[TBL] [Abstract][Full Text] [Related]
18. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
19. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
20. "High-risk stigmata" of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Aso T; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Ideno N; Osoegawa T; Takahata S; Shindo K; Ushijima Y; Aishima S; Oda Y; Ito T; Mizumoto K; Tanaka M
Pancreas; 2014 Nov; 43(8):1239-43. PubMed ID: 25036910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
